Smoking, coffee intake, and Parkinson's disease: Potential protective mechanisms and components

被引:0
作者
Hong, Sa Weon [1 ]
Page, Rachel [1 ]
Truman, Penelope [1 ]
机构
[1] Massey Univ, Sch Hlth Sci, Wellington 6021, New Zealand
关键词
Parkinson's disease; Smoking; Coffee drinking; Phenolic compounds; Monoamine oxidase B; Catechol O -methyltransferase; CATECHOL-O-METHYLTRANSFERASE; MONOAMINE-OXIDASE-B; 6-HYDROXYDOPAMINE RAT MODEL; NRF2 TRANSCRIPTION FACTOR; NF-KAPPA-B; ALPHA-SYNUCLEIN; CAFFEIC ACID; OXIDATIVE STRESS; FERULIC ACID; MOUSE MODEL;
D O I
10.1016/j.neuro.2024.12.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a common progressive neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Environmental and lifestyle factors, such as smoking and coffee drinking, have been associated with a decreased risk for PD. However, the biological mechanisms underlying protective effects on PD are still not fully understood. It has been suggested that nonnicotine components in cigarette smoke and non-caffeine components in coffee may contribute to this protective effect. The aim of this review was to explore candidate molecules and mechanisms behind the effects of smoking and coffee drinking on PD by integrating findings from previous studies. By cross-referencing an index of tobacco constituents and a list of coffee constituents with existing literature on natural compounds and their structural analogs that show inhibitory activities against monoamine oxidase B, catechol O-methyltransferase, and alpha-synuclein fibrillation, we have identified tobacco and coffee components that inhibit these targets. Furthermore, tobacco and coffee components potentially play roles in suppressing neuroinflammation, activating the Nrf2 pathway as natural activators, and altering the gut microbiome. This review suggests that the phenolic compounds from tobacco and coffee investigated may contribute to the low incidence of PD in smokers and coffee drinkers, showing moderate to strong potential as therapeutic interventions. The current review suggests that multifunctional molecules found in coffee and cigarette smoke may have potential neuroprotective effects, but none of the data indicates that multifunctionality is required for these effects. This review will deepen our understanding of how smoking and coffee drinking are linked to a reduced risk of PD and will also be important in elucidating the mechanisms underlying the protective effects of smoking and coffee drinking on PD.
引用
收藏
页码:48 / 63
页数:16
相关论文
共 50 条
  • [31] Neuroprotective role of coconut oil for the prevention and treatment of Parkinson's disease: potential mechanisms of action
    Deepika, N. P.
    Kondengadan, Mohammed Shameer
    Sweilam, Sherouk Hussein
    Rahman, Md. Habibur
    Muhasina, K. M.
    Ghosh, Puja
    Bhargavi, Divya
    Palati, Divya Jyothi
    Maiz, Fathi
    Duraiswamy, B.
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2022, 40 (04) : 3346 - 3378
  • [32] Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease
    Li, Yanwei
    Zhao, Jinying
    Holscher, Christian
    CNS DRUGS, 2017, 31 (08) : 639 - 652
  • [33] Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential
    Liu, Cui
    Xue, Yan
    Liu, Mei-Fang
    Wang, Ying
    Chen, Lei
    NEUROCHEMISTRY INTERNATIONAL, 2020, 138
  • [34] Therapeutic potential and limitation of condensed and hydrolyzed tannins in Parkinson's disease
    Zhao, Runfan
    Jia, Nan
    Wu, Shuyang
    Wen, Jiahui
    Huang, Yajun
    Zhao, Chao
    Chen, Weichao
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 307
  • [35] Neural and Immune Mechanisms in the Pathogenesis of Parkinson's Disease
    Blandini, Fabio
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (01) : 189 - 201
  • [36] Neuroinflammation in Parkinson's Disease: Triggers, Mechanisms, and Immunotherapies
    Wang, Tai
    Shi, Changhe
    Luo, Haiyang
    Zheng, Huimin
    Fan, Liyuan
    Tang, Mibo
    Su, Yun
    Yang, Jing
    Mao, Chengyuan
    Xu, Yuming
    NEUROSCIENTIST, 2022, 28 (04) : 364 - 381
  • [37] Parkinson's disease, smoking, and family history
    Elbaz, A
    Manubens-Bertram, JM
    Baldereschi, M
    Beteler, MMB
    Grigoletto, F
    Lopez-Pousa, S
    Dartigues, JF
    Alpérovitch, A
    Rocca, WA
    Tzourio, C
    JOURNAL OF NEUROLOGY, 2000, 247 (10) : 793 - 798
  • [38] Smoking and Parkinson's disease: Explanatory hypothesis
    Allam, MF
    Del Castillo, AS
    Navajas, RFC
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2002, 112 (07) : 851 - 854
  • [39] Parkinson's disease protects against smoking?
    Allam, MF
    Campbell, MJ
    Del Castillo, AS
    Navajas, RFC
    BEHAVIOURAL NEUROLOGY, 2004, 15 (3-4) : 65 - 71
  • [40] History of Smoking and Olfaction in Parkinson's Disease
    Lucassen, Elisabeth B.
    Sterling, Nicholas W.
    Lee, Eun-Young
    Chen, Honglei
    Lewis, Mechelle M.
    Kong, Lan
    Huang, Xuemei
    MOVEMENT DISORDERS, 2014, 29 (08) : 1069 - 1074